Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.


TSX:CPH - Post by User

Comment by maxxie3on Aug 14, 2020 3:30pm
112 Views
Post# 31410252

RE:RE:RE:RE:Rapid Growth of Isotrention Market in Q1/20

RE:RE:RE:RE:Rapid Growth of Isotrention Market in Q1/20
The money will continue to roll in as the SP goes down ? Very interesting you also forgot to add for every good quarter , the negative surprises or as one of the most hated posters mentioned the "One Time Events" this quarter one-time tax adjustment
you have to admit he is right and the next quarter what one-time surprise Is it. As a long-suffering shareholder, I am tired of it I would not be kissing management AZZEZ just yet .  We are lucky shares are being bought by the company with no new buyers moving in who knows how low this stock would have sunk. Bragging rights goes to the ones who were lucky enough to sell for a profit for now. Only thing that matters to me is what the SP is doing now and it's not good. Also, the company did not sound overly confident about Trulance or maybe it just the way I feel a little better guidance would help.
<< Previous
Bullboard Posts
Next >>